88 related articles for article (PubMed ID: 8222189)
1. A comparative study of heparin responses in arterial and venous thromboembolism using molecular markers for thrombosis.
Sobel M; Sternbergh WC; Marques D; Grimsdale AS
Circulation; 1993 Nov; 88(5 Pt 2):II426-31. PubMed ID: 8222189
[TBL] [Abstract][Full Text] [Related]
2. [Is the assessment of prothrombin fragment F1+2 for monitoring of heparin therapy in patients with deep vein thrombosis useful?].
Korte W; Corbetta C; Schmid L
Schweiz Med Wochenschr; 1995 Mar; 125(9):420-3. PubMed ID: 7892570
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
Levine MN; Hirsh J; Gent M; Turpie AG; Cruickshank M; Weitz J; Anderson D; Johnson M
Arch Intern Med; 1994 Jan; 154(1):49-56. PubMed ID: 8267489
[TBL] [Abstract][Full Text] [Related]
4. Activation of coagulation and deep vein thrombosis after bone marrow harvesting and insertion of a Hickman-catheter in ABMT patients with malignant lymphoma.
Sletnes KE; Holte H; Halvorsen S; Jakobsen E; Wisløff F; Kvaløy S
Bone Marrow Transplant; 1996 Apr; 17(4):577-81. PubMed ID: 8722358
[TBL] [Abstract][Full Text] [Related]
5. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
[TBL] [Abstract][Full Text] [Related]
6. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Murakoshi T
Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
[TBL] [Abstract][Full Text] [Related]
7. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
Papalambros E; Sigala F; Travlou A; Bastounis E; Mirilas P
J Am Coll Surg; 2004 Jul; 199(1):69-77. PubMed ID: 15217633
[TBL] [Abstract][Full Text] [Related]
8. Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism.
Kyrle PA; Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Melichart M; Traxler G; Weltermann A; Speiser W; Lechner K
Thromb Haemost; 1997 May; 77(5):829-33. PubMed ID: 9184387
[TBL] [Abstract][Full Text] [Related]
9. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
[TBL] [Abstract][Full Text] [Related]
10. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
[TBL] [Abstract][Full Text] [Related]
11. Physician-guided treatment compared with a heparin protocol for deep vein thrombosis.
Elliott CG; Hiltunen SJ; Suchyta M; Hull RD; Raskob GE; Pineo GF; Jensen RL; Yeates S; Kitterman N
Arch Intern Med; 1994 May; 154(9):999-1004. PubMed ID: 8179457
[TBL] [Abstract][Full Text] [Related]
12. Increases in circulating levels of monocyte-platelet and neutrophil-platelet complexes following hip arthroplasty.
Bunescu A; Widman J; Lenkei R; Menyes P; Levin K; Egberg N
Clin Sci (Lond); 2002 Mar; 102(3):279-86. PubMed ID: 11869168
[TBL] [Abstract][Full Text] [Related]
13. The John Charnley Award. Thrombogenesis during total hip arthroplasty.
Sharrock NE; Go G; Harpel PC; Ranawat CS; Sculco TP; Salvati EA
Clin Orthop Relat Res; 1995 Oct; (319):16-27. PubMed ID: 7554626
[TBL] [Abstract][Full Text] [Related]
14. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
[TBL] [Abstract][Full Text] [Related]
15. Different effects of heparin in males and females.
Campbell NR; Hull RD; Brant R; Hogan DB; Pineo GF; Raskob GE
Clin Invest Med; 1998 Apr; 21(2):71-8. PubMed ID: 9562927
[TBL] [Abstract][Full Text] [Related]
16. Heparin therapy in pediatric patients: a prospective cohort study.
Andrew M; Marzinotto V; Massicotte P; Blanchette V; Ginsberg J; Brill-Edwards P; Burrows P; Benson L; Williams W; David M
Pediatr Res; 1994 Jan; 35(1):78-83. PubMed ID: 8134203
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
18. Markers of hemostatic system activation in acute deep venous thrombosis-evolution during the first days of heparin treatment. The DVTENOX Study Group.
Thromb Haemost; 1993 Dec; 70(6):909-14. PubMed ID: 8165610
[TBL] [Abstract][Full Text] [Related]
19. Management of heparin therapy: Controlled prospective trial.
Salzman EW; Deykin D; Shapiro RM; Rosenberg R
N Engl J Med; 1975 May; 292(20):1046-50. PubMed ID: 1091856
[TBL] [Abstract][Full Text] [Related]
20. Coagulation responses to heparin in the ischemic limb: assessment of thrombin and platelet activation during vascular surgery.
Sobel M; Gervin CA; Qureshi DG; Greenfield LJ
Circulation; 1987 Sep; 76(3 Pt 2):III8-13. PubMed ID: 2957118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]